Clinical Trial Update: The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Echinacea (Immulant) for treating cryptosporidiosis in immunocompromised children; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis

Drugs mentioned

• Immulant (Echinacea)

Snippet

Sponsor: Al-Azhar University | Conditions: Cryptosporidium Infection | Phase 2 | Status: RECRUITING